Artificial intelligence is being utilized to accelerate drug discovery, with various companies and institutions collaborating on initiatives to leverage ai for this purpose. Partnerships between tech companies, pharmaceutical firms, and research institutions are being formed to develop and apply ai in areas such as image analysis and data infrastructure. The use of ai in drug discovery is being explored for a range of diseases, including multiple sclerosis, myeloma, and cancer.